Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
38.5M
-
Number of holders
-
38
-
Total 13F shares, excl. options
-
25M
-
Shares change
-
+2.02M
-
Total reported value, excl. options
-
$32M
-
Value change
-
+$2.56M
-
Number of buys
-
13
-
Number of sells
-
-13
-
Price
-
$1.28
Significant Holders of Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) as of Q2 2023
43 filings reported holding BOLT - Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share as of Q2 2023.
Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25M shares
of 38.5M outstanding shares and own 65% of the company stock.
Largest 10 shareholders include Vivo Capital, LLC (3.87M shares), TANG CAPITAL MANAGEMENT LLC (3.33M shares), CITADEL ADVISORS LLC (2.99M shares), Sofinnova Investments, Inc. (2.75M shares), Pivotal bioVenture Partners Investment Advisor LLC (1.89M shares), ORBIMED ADVISORS LLC (1.54M shares), Nan Fung Group Holdings Ltd (1.17M shares), Samsara BioCapital, LLC (1.05M shares), Newtyn Management, LLC (1M shares), and VANGUARD GROUP INC (928K shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.